Hikma Pharmaceuticals (HKMPF)
(Delayed Data from OTC)
$26.38 USD
0.00 (0.00%)
Updated Jul 30, 2025 11:06 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Hikma Pharmaceuticals Plc has a market cap of $5.85B, which represents its share price of $26.38 multiplied by its outstanding shares number of 221.89M. As a mid-cap company, HKMPF's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
HKMPF 26.38 0.00(0.00%)
Will HKMPF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HKMPF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HKMPF
Hikma Pharmaceuticals (HKMPF) Upgraded to Buy: Here's What You Should Know
HKMPF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for HKMPF
Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Pre Recorded Earnings Call Transcript
Hikma Pharmaceuticals PLC 2025 Q2 - Results - Earnings Call Presentation
Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call Transcript
Hikma price target lowered to 2,500 GBp from 2,600 GBp at JPMorgan
Hikma Pharmaceuticals PLC (HKMPF) (H1 2025) Earnings Call Highlights: Strong Revenue Growth ...